Log in
Enquire now
‌

Bioverativ

Bioverativ is a global biotechnology company developing therapies for hemophilia and other rare blood disorders, including sickle cell disease and beta-thalassemia.

OverviewStructured DataIssuesContributors

Contents

bioverativ.com
bioverativ.com...ge.aspx
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Regenerative medicine
Regenerative medicine
Location
Waltham, Massachusetts
Waltham, Massachusetts
B2X
B2B
B2B
0
Pitchbook URL
pitchbook.com/profiles...169838-02
Parent Organization
Sanofi
Sanofi
Spun Out From
Biogen
Biogen
Number of Employees (Ranges)
201 – 5000
Full Address
225 2nd Ave, Waltham, MA 02451, US0
CIK Number
1,681,6890
Place of Incorporation
Delaware
Delaware
0
DUNS Number
0804857970
IRS Number
813,461,3100
Founded Date
2017
0
CAGE Code
7WTM80
Patents Assigned (Count)
52
Country
United States
United States
Russia
Russia

Other attributes

Acquirer
Sanofi
Sanofi
0
Company Operating Status
Active
Public/Private
Public0
SIC Code
2,8340
Wikidata ID
Q28155329
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Bioverativ

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.